2022, Number 2
<< Back Next >>
CorSalud 2022; 14 (2)
Coexistent ventricular preexcitation and Brugada sign: A rare condition
Dorantes SM, Borroto GE, Castro HJA, Martínez LF, Castañeda CO, Falcón RR, de la Vega VK
Language: Spanish
References: 15
Page: 193-198
PDF size: 798.09 Kb.
ABSTRACT
The coexistence of ventricular preexcitation and Brugada syndromes is very rare, no relationship has been established between them and so far they are considered separate diseases. Both are arrhythmogenic, can cause sudden death and their treatment is difficult; since some drugs used to prevent tachycardia can cause a Brugada sign. We present two patients with common characteristics: absence of structural heart disease demonstrable by conventional methods, frequent and symptomatic orthodromic tachycardias, ventricular pre-excitation and Brugada sign (both evident and intermittent), without clinical malignant ventricular ar-rhythmias; which is why programmed electrical stimulation was not performed to try to provoke them. Some singularities are discussed, such as the association of intranodal and orthodromic reentrant tachycardias in the patient in whom acces-sory pathway ablation was performed, and the difficulty of the therapeutic ap-proach in the patient who did not agree to undergo the procedure.
REFERENCES
Eckardt L, Kirchhof P, Johna R, Haverkamp W, Breithardt G, Borggrefe M. Wolff-Parkinson-White syndrome associated with Brugada syndrome. Pacing Clin Electrophysiol. 2001;24(9 Pt 1):1423-4. [DOI]
De Roy L, Popescu E, Floria M, Blommaert D, De-ceuninck O, Collet B, et al. Variable morphologies of preexcitation due to a concomitant Brugada pattern. J Interv Card Electrophysiol. 2007;20(1-2):39-41. [DOI]
Jaiswal A, Heretis K, Goldbarg S. Coexistent Bru-gada Syndrome and Wolff-Parkinson-White Syn-drome: What is the Optimal Management? Indian Pacing Electrophysiol J. 2013;13(5):173-7. [DOI]
Kaiser E, Sacilotto L, Darrieux F, Sosa E. Coexist-ence of Wolff-Parkinson-white and Brugada syn-drome: mere curiosity? Ann Noninvasive Elec-trocardiol. 201;19(5):504-7. [DOI]
Bodegas AI, Arana JI, Vitoria Y, Arriandiaga JR, Barrenetxea JI. Brugada syndrome in a patient with accessory pathway. Europace. 2002;4(1):87-9. [DOI]
Aksan G, Tezcan M, Çevrim Ö, Elitok A, Bilge AK. Coexistence of Brugada and Wolff Parkinson White syndromes: A case report and review of the literature. Turk Kardiyol Dern Ars. 2018;46(6): 488-93. [DOI]
Erdoğan O. Coexistence of Wolff-Parkinson-White and Brugada ECG. Turk Kardiyol Dern Ars. 2018; 46(6):433-4. [DOI]
Khazan B, Curl K, Ho R. Brugada pattern with a concurrent accessory pathway. JACC Clin Elec-trophysiol. 2017;3(8):911-2. [DOI]
Márquez MF, Cárdenas M. La controversia de la utilidad de la estimulación ventricular para la es-tratificación de riesgo en el síndrome de Brugada. CorSalud [Internet]. 2015 [citado 4 Jun 2021];7(3): 158-60. Disponible en:http://www. revcorsalud. sld. cu/index. php/cors/article/view/52/112
Dorantes Sánchez M, Trung Chinh P. Estimula-ción eléctrica programada del corazón en el sín-drome de Brugada. Parte I: Una visión actual. Cor-Salud [Internet]. 2015 [citado 5 Jun 2021];7(1):46-51. Disponible en:http://www. revcorsalud. sld. cu/index. php/cors/article/view/11/11
Dorantes Sánchez M, Trung Chinh P. Estimula-ción eléctrica programada del corazón en el sín-drome de Brugada. Parte II. Variaciones sobre un mismo tema. CorSalud [Internet]. 2015 [citado 5 Jun 2021];7(3):202-13. Disponible en:http://www. revcorsalud. sld. cu/index. php/cors/article/view/59/96
Belhassen B. Is quinidine the ideal drug for bru-gada syndrome? Heart Rhythm. 2012;9(12):2001-2. [DOI]
Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shi-mizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm. 2009;6(3):401-4. [DOI]
Viskin S, Antzelevitch C, Márquez MF, Belhassen B. Quinidine: a valuable medication joins the list of 'endangered species'. Europace. 2007;9(12): 1105-6. [DOI]
Dorantes Sánchez M. Apunte histórico sobre la quinidina. CorSalud [Internet]. 2013 [citado 6 Jun 2021];5(4):361-5. Disponible en:http://www. revcorsalud. sld. cu/index. php/cors/article/view/474/883